Page last updated: 2024-09-05

lenalidomide and Osteosclerosis

lenalidomide has been researched along with Osteosclerosis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akiyama, H; Hara, D; Hasegawa, Y; Hoshikawa, M; Nukui, S; Shimizu, T1
Balducci, M; Chiusolo, P; De Stefano, V; Giannotta, C; Laurenti, L; Leone, G; Luigetti, M; Sabatelli, M; Sica, S; SorĂ , F; Vannata, B1
Li, J; Zhou, DB1

Reviews

1 review(s) available for lenalidomide and Osteosclerosis

ArticleYear
New advances in the diagnosis and treatment of POEMS syndrome.
    British journal of haematology, 2013, Volume: 161, Issue:3

    Topics: Antibodies, Monoclonal, Humanized; Bevacizumab; Boronic Acids; Bortezomib; Castleman Disease; Chromosome Aberrations; Combined Modality Therapy; Dexamethasone; Disease Management; Drug Therapy, Combination; Genes, Immunoglobulin; Humans; Hypertension, Pulmonary; Lenalidomide; Melphalan; Osteosclerosis; Peripheral Blood Stem Cell Transplantation; Plasma Cells; POEMS Syndrome; Prognosis; Pyrazines; Severity of Illness Index; Symptom Assessment; Thalidomide; Transplantation, Autologous; Vascular Endothelial Growth Factor A

2013

Other Studies

2 other study(ies) available for lenalidomide and Osteosclerosis

ArticleYear
Utility of osteosclerotic lesion biopsy in diagnosis of POEMS syndrome: A case report.
    Medicine, 2017, Volume: 96, Issue:41

    Topics: Arthritis, Rheumatoid; Cell Proliferation; Diagnosis, Differential; Female; Humans; Immunoelectrophoresis; Immunologic Factors; Lenalidomide; Lupus Erythematosus, Systemic; Middle Aged; Neurologic Examination; Osteosclerosis; Plasma Cells; POEMS Syndrome; Sjogren's Syndrome; Thalidomide; Treatment Outcome

2017
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation.
    American journal of hematology, 2012, Volume: 87, Issue:6

    Topics: Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Humans; Humerus; Immunologic Factors; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Osteosclerosis; Peripheral Blood Stem Cell Transplantation; POEMS Syndrome; Prednisolone; Recurrence; Salvage Therapy; Thalidomide; Transplantation, Autologous

2012